GOING DEEPER ON ATOPIC DERMATITIS: PATHOPHYSIOLOGY TO THE MANAGEMENT OF MODERATE-TO-SEVERE DISEASE

PRODUCT THEATRE WITH BREAKFAST

Saturday, May 6, 2017

 
Time: 7:00 am - 8:00 am
Room: Metro West Ballroom

This activity is jointly provided by Global Education Group and Integritas Communications.
This activity is supported by an educational grant from Genzyme, a Sanofi Company, and Regeneron Pharmaceuticals.

 
Faculty

Jeffrey M. Weinberg, MD-Virtual Professor
Associate Clinical Professor of Dermatology
Icahn School of Medicine at Mount Sinai
New York, New York
Director, Division of Dermatology
Jamaica Hospital Medical Center
Richmond Hill, New York

Lawrence F. Eichenfield, MD
Professor of Dermatology and Pediatrics
Vice Chair, Department of Dermatology
University of California, San Diego, School of Medicine
Chief, Pediatric and Adolescent Dermatology
Rady Children’s Hospital
San Diego, California

Melinda Gooderham, MD, FRCPC
Assistant Professor
Queen’s University
Kingston, Ontario, Canada
Medical Director
SKiN Centre for Dermatology
Peterborough, Ontario, Canada
 
Target Audience

The educational design of this activity addresses the needs of dermatologists, allergists, and other clinicians who treat patients with moderate-to-severe atopic dermatitis.

Statement of Need/Program Overview

Atopic dermatitis is a chronic inflammatory condition with manifestations in the skin and in other organ systems throughout the body.1 Increasing in prevalence over the last 2 decades, the disease places tremendous burdens on patients, family members, and caregivers.1,2 The evolving understanding of disease pathophysiology and widespread effects on patient health and quality of life highlight the need for prompt diagnosis and proactive management.3,4 Moreover, research into the mechanisms underlying atopic dermatitis pathogenesis and progression has led to new approaches to disease characterization and treatment.5,6 This Interactive Exchange™ program will open with a brief 3D-animated video highlighting mechanistic insights into atopic dermatitis development. Expert faculty will then discuss best practices in comprehensive patient evaluations, and the clinical profiles, efficacy, and safety of treatment options for moderate-to-severe disease, including biologic therapy. With the overall goal of improving outcomes for patients with moderate-to-severe atopic dermatitis, the program will integrate clinical data and professional experience into actionable recommendations that can be used to individualize care and improve patient-clinician communication.

References:

  1. Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab. 2015:66(suppl 1):8-16.
  2. Drucker AM, et al. The burden of atopic dermatitis: summary of a report for the National Eczema Association. J Invest Dermatol. 2017;137(1):26-30.
  3. Eichenfield LF, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70(2):338-351.
  4. Sidbury R, et al. Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents. J Am Acad Dermatol. 2014;71(2): 327-349.
  5. Ungar B, et al. An integrated model of atopic dermatitis biomarkers highlights the systemic nature of the disease. J Invest Dermatol. 2017;137(3):603-613.
  6. Simpson EL, et al. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med. 2016;375(24):2335-2348.

 
Educational Objectives

After completing this activity, the participant should be better able to:

• Discuss pathophysiologic mechanisms and risk factors that contribute to atopic dermatitis development and persistence, including potential treatment targets
• Evaluate patients with atopic dermatitis over time for persistent symptoms, comorbidities, and treatment responses
• Describe the clinical profiles of current and emerging biologic therapies for moderate-to-severe atopic dermatitis
• Tailor long-term therapy for moderate-to-severe atopic dermatitis to prevent exacerbations, maximize health-related quality of life, manage comorbidities, and minimize adverse events
• Educate patients and caregivers to improve their understanding of atopic dermatitis, provide Action Plans to reduce exacerbations, and promote shared decision-making

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Integritas Communications. Global is accredited by the ACCME to provide continuing medical education for physicians.

This CME/CE activity complies with all requirements of the federal Physician Payment Sunshine Act. If a reportable event is associated with this activity, the accredited provider managing the program will provide the appropriate physician data to the Open Payments database.

Physician Credit Designation

Global Education Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouses/life partners who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Americans with Disabilities Act

Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Mike Remsen prior to the live event at (646)-350-0906 or mremsen@integritsgrp.com.

For information about the accreditation of this program, please contact Global at (303)-395-1782 or cme@globaleducationgroup.com
 
 
This is a CME accredited session

Go to top